Professor Martin and colleague David Q. Matus, PhD, are using state-of-the-art microscopy and genetic analysis of circulating tumor cells to achieve an unprecedented level of understanding about how these cells exit blood vessels and invade news sites on the body.

To help accelerate breakthroughs in cancer research, the Pershing Square Research Alliance has invested $25 million in next generation medical research talent.